Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 382

Menopause

NICE guideline [NG23] Menopause: identification and management. Last updated: Apr 2026.

NICE CKS Menopause. Last revised: Jul 2025.

Menopause

Menopause is the permanent cessation of menstruation due to loss of ovarian follicular activity, usually occurring between 45-55 years of age.

This updated UKMLA guide to menopause is based on NICE NG23 and NICE CKS, which covers definitions, symptoms, complications, diagnosis, and management.

Definitions

Menopause refers to the biological stage where menstruation stops permanently due to loss of ovarian follicular activity.

Some other closely related terms:

Term Definition
Early menopause Menopause that happens between 40-45 y/o
Peri-menopause The period before menopause, where there are irregular cycles of ovulation and menstruation
Post-menopause The period after menstruation has not occurred for 12 consecutive months
Premature ovarian insufficiency (premature ovarian failure) Transient or permanent loss of ovarian function before 40 y/o

Expected Timing

Menopause usually happens between 45-55 y/o, mean age of menopause is 51 y/o

Early menopause is defined as menopause happening between 40-45 y/o

Causes and Risk Factors

Most common cause: physiological age-related menopause

  • Women are born with a fixed number of oocytes, which reduces with each menstrual cycle
  • Menopause is characterised by the depletion of the oocyte store and the cessation of menstruation

Iatrogenic causes of menopause:

  • Bilateral oophorectomy
  • Gonadotoxic medications (e.g. GnRH agonist)
  • Pelvic radiotherapy
  • Chemotherapy

Risk factors for early menopause:

  • Early menarche
  • Nulliparity / low parity
  • Smoking
  • Underweight

Clinical Features

Menopausal symptoms typically last for 7–9 years. ~20% of women experience symptoms for up to 15 years.

Changes in menstrual cycle During peri-menopause

  • Cycles become irregular: cycle length may shorten to 2–3 weeks or lengthen to many months
  • Amount of menstrual bleeding may change, commonly increases slightly

When menopause occurs: complete amenorrhoea (if the person is not using HRT or hormonal contraception)

Vasomotor symptoms
  • Hot flushes
    • A sudden feeling of heat in the upper body that spreads downwards
    • Can be associated with profuse sweating, palpitations, or anxiety
  • Night sweats → sleep disturbances

Caffeine, spicy food and alcohol may trigger vasomotor symptoms

Urogenital symptoms (genitourinary syndrome of menopause) Urogenital symptoms arise from vulvovaginal atrophy (caused by declining oestrogen levels):

  • Vulvovaginal symptoms (dryness / irritation / discomfort / burning / itching)
  • Dyspareunia
  • Dysuria
  • Urinary frequency and urgency
  • Recurrent UTIs
Cognitive impairment and mood disorders
  • Low mood and other depressive symptoms
  • Anxiety
  • Labile mood
  • Irritability

Mood disorders can also result in sleep disturbances

Sexual dysfunction Loss of sexual desire and libido can result from:

  • Dyspareunia (from vulvovaginal atrophy)
  • Declining levels of oestrogen and testosterone as the ovaries fail
Other features
  • Joint and muscle pains
  • Headache
  • Fatigue

Complications

Post-menopausal women are at increased risk of:

  • Osteoporosis and associated fragility fractures
  • Cardiovascular diseases
  • Cerebrovascular disease (stroke and TIA)

Investigation and Diagnosis

Menopause can be diagnosed clinically (with no blood tests) if a patient is:

  • ≥45 y/o, AND
  • Has ≥12 months of amenorrhoea

If a <45 y/o woman presents with menopause symptoms → measure serum FSH level (take 2 samples, 4-6 weeks apart):

  • Persistently elevated FSH indicates reduced ovarian function
  • The exact diagnosis depends on the age of the patient:
    • 40-44 y/oearly menopause
    • <40 y/o → premature ovarian insufficiency

Consider performing a pregnancy test to exclude pregnancy as a cause of amenorrhoea.

Do not measure FSH levels to identify menopause in those who are taking COCP or high-dose progestogen or tamoxifen.

Do NOT use the following tests to identify menopause in people aged 45 or over:

  • Anti-Müllerian hormone
  • Inhibin A and B
  • Oestradiol
  • Antral follicle count
  • Ovarian volume

Management

Tailor management to the patient’s presenting symptoms and priorities; do not offer all treatments routinely.

Menopause symptom Recommended management
Vasomotor symptoms (hot flushes / night sweats)
  • 1st line: HRT (see the Hormone Replacement Therapy (HRT) article)
  • 2nd line: menopause-specific CBT  (in addition to HRT or alone with HRT not appropriate)
  • 3rd line: SSRIs / SNRIs / clonidine
Urogenital symptoms (genitourinary syndrome of menopause)
  • 1st line: vaginal oestrogen +/- non-hormonal vaginal moisturisers / lubricants
    • Options of vaginal oestrogen: tablets, creams, pessaries, gels
    • Vaginal tablets and creams should be used nightly for 2 weeks (3 weeks for pessary and gel) and then twice weekly (maintenance dose)
    • Maintenance dosing is important as symptoms frequently recur on cessation
  • 2nd line: non-hormonal vaginal moisturisers / lubricants alone
  • 3rd line: vaginal prasterone
  • 4th line: oral ospemifene

Vaginal oestrogen should be avoided in those with a personal history of breast cancer → offer non-hormonal vaginal moisturisers / lubricants as 1st line.

Depressive symptoms Consider:

  • HRT
  • CBT
Sleep disturbances Consider menopause-specific CBT
Low sexual desire / libido Consider testosterone supplementation if HRT alone is not effective

References


Related Articles

Hormone Replacement Therapy (HRT)

Premature Ovarian Insufficiency

Contraception (Non-Emergency)

Osteoporosis

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Be first to accessour QBank

Sign up to receive major guideline updates and early access when we launch.